Polarisqb, Developers Of First Quantum Drug Discovery Platform, Announces Seed Investment Of $2.1 Million
Polarisqb, Developers Of First Quantum Drug Discovery Platform, Announces Seed Investment Of $2.1 Million
08/11/21, 1:14 PM
Location
Round Type
seed
POLARISqb, the Durham based developer of the world's first drug discovery software built for quantum computers, announces that it has received the first round of their seed raise, totalling over two million dollars. This funding will allow Polaris to grow their team, scale the platform and develop assets faster.
Company Info
Location
durham, north carolina, united states
Additional Info
Founded in 2020 by Shahar Keinan, CEO, and Bill Shipman, CTO, POLARISqb uses the latest innovations in cloud, quantum computing, artificial intelligence, and machine learning to operate 10,000 times faster than any alternative solutions in the market. About Polaris POLARISqb is the first drug discovery platform built on a quantum computer.